MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
1.740
+0.040
+2.35%
Pre Market: 1.822 +0.082 +4.71% 04:30 11/10 EST
OPEN
1.690
PREV CLOSE
1.700
HIGH
1.770
LOW
1.640
VOLUME
27
TURNOVER
0
52 WEEK HIGH
10.43
52 WEEK LOW
1.610
MARKET CAP
14.78M
P/E (TTM)
-0.0358
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SCLX last week (1102-1106)?
Weekly Report · 1d ago
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Benzinga · 3d ago
Datavault AI Fires CEO Nathaniel Bradley
Benzinga · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 11/02 12:05
Weekly Report: what happened at SCLX last week (1026-1030)?
Weekly Report · 11/02 09:41
Datavault AI Stock (DVLT) Plunges Nearly 50% over $150 Million Bitcoin Controversy Before Rebounding 22% Today
TipRanks · 10/28 16:50
Datavault AI Stock Crashes — Financials Cannot Be Trusted: What You Need to Know
Benzinga · 10/27 16:31
Weekly Report: what happened at SCLX last week (1019-1023)?
Weekly Report · 10/26 09:41
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.